跳至主要内容
临床试验/NCT05241821
NCT05241821已完成不适用

Management and Outcomes of Acute STROke Complicating Transcatheter Aortic Valve Implantation

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 484 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
484
试验地点
1
主要终点
Neurologic disability free survival

研究概览

简要总结

Periprocedural complications of trans catheter aortic valve implantation, and particularly the occurrence of stroke has a marked impact on survival and quality of life. The characteristics of periprocedural stroke complicating TAVI, and particularly of interventions aimed to treat stroke complicating TAVI have not been systematically described. We therefore aimed is to explore the incidence and characteristics of acute stroke complicating TAVI and to describe the safety and efficacy of emergent interventions to treat acute stroke complicating TAVI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who have had a stroke within 30 days of TAVI

排除标准

  • 未提供

研究组 & 干预措施

Neuro-intervention

patients with periprocedural stroke after TAVI, treated with neuro-intervention

干预措施: Thrombolytic Agent (Drug)

Neuro-intervention

patients with periprocedural stroke after TAVI, treated with neuro-intervention

干预措施: Mechanical thrombectomy (Procedure)

结局指标

主要结局

Neurologic disability free survival

时间窗: 90 days

modified rankin score (mRS) 0/1

All cause mortality

时间窗: 1-year

All cause death

次要结局

  • Bleeding complications(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amos Levi

MD

Rabin Medical Center

研究点 (1)

Loading locations...

相似试验